Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Neoplasm
82%
Nanomedicine
62%
Malignant Neoplasm
37%
Micelle
31%
Nanoparticle
30%
Drug Delivery System
25%
Doxorubicin
25%
Inflammation
20%
Chemotherapy
19%
Tumor Growth
18%
Combination Therapy
15%
Dexamethasone
13%
Fibrosis
12%
Microsphere
12%
Atherosclerosis
12%
Anti-Inflammatory Drug
11%
Macrogol
11%
Prednisolone
11%
Blood-Brain Barrier
9%
Diseases
9%
Copolymer
9%
Hyperthermia
9%
Nanobody
9%
Liver Fibrosis
8%
Biodistribution
8%
Superparamagnetic Iron Oxide Nanoparticle
8%
Mouse Model
8%
Nevus flammeus
8%
Nanocarrier
8%
Polyethylene Glycol
7%
microRNA
7%
Pharmacokinetics
7%
Targeted Drug Delivery
7%
Docetaxel
7%
Polymersome
7%
Tumor Model
7%
Optical Imaging
7%
Paclitaxel
6%
Glucocorticoid
6%
Liver Injury
6%
Clinical Trial
6%
Natural Product
6%
N-(2-Hydroxypropyl) Methacrylamide
6%
Tumor Vaccine
6%
Therapeutic Effect
6%
Preclinical Study
6%
Transferrin
6%
Epidermal Growth Factor Receptor
6%
Arthritis
6%
Keyphrases
Liposomes
96%
Nanomedicine
52%
Liposomal
31%
Tumor
27%
Microbubbles
23%
Drug Delivery
21%
Drug Delivery System
19%
Nanoparticles
16%
Inflammation
15%
Macrophages
15%
Ultrasound
15%
Tumor Growth
15%
Endothelial Cells
14%
Polyethylene Glycol
13%
Clinical Translation
13%
Polymeric Micelles
12%
Tumor Stroma
11%
Doxorubicin
11%
Core-crosslinked Polymeric Micelles
10%
Port-wine Stain
10%
Fibrosis
10%
Dendritic Cells
10%
Chemotherapy
10%
Loaded Liposomes
9%
Biodistribution
9%
Thermosensitive Liposomes
9%
Blood-brain Barrier
9%
Immune Cells
9%
Prednisolone
9%
Tumor Cells
8%
Enhanced Retention
8%
Tumor Targeting
8%
Superparamagnetic Iron Oxide Nanoparticles (SPIONs)
8%
Enhanced Permeability
8%
Immunoliposomes
8%
CD169+ Macrophages
8%
Liposome-encapsulated
8%
Therapeutic Efficacy
8%
CD169
8%
Drug Target
8%
CD8+ T Cells
8%
Liver Fibrosis
7%
Angiogenic
7%
Lipid Nanoparticles
7%
Nanotherapeutics
7%
Therapeutic Effect
7%
Small Interfering RNA (siRNA)
7%
Hepatic Stellate Cell Activation
7%
Polymersomes
7%
Anticancer Drugs
7%
